Skip to main content
PMC home page
Gut logoLink to Gut
. 1986 Jan;27(1):106–110. doi: 10.1136/gut.27.1.106

Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.

I Hamilton, H J O'Connor, N C Wood, I Bradbury, A T Axon
PMCID: PMC1433172  PMID: 3512382

Abstract

Eighty patients with duodenal ulcer were randomly allocated to treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Ulcers healed in 78% of patients treated with TDB and in 74% treated with cimetidine, supporting previous observations that the efficacy of these two agents is similar. Duodenal ulcer recurred in 43% of patients in the 12 months after treatment with TDB and in 78% of patients treated with cimetidine, with a significantly greater incidence of recurrence 6-12 months after cimetidine treatment. Tripotassium dicitrato bismuthate tablets may be preferable to cimetidine in the initial management of duodenal ulcer, because they offer a smaller likelihood of recurrence in the 12 months after successful treatment.

Full text

PDF
107

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bianchi Porro G., Lazzaroni M., Petrillo M., De Nicola C. Relapse rates in duodenal ulcer patients formerly treated with bismuth subcitrate or maintained with cimetidine. Lancet. 1984 Sep 22;2(8404):698–698. doi: 10.1016/s0140-6736(84)91258-3. [DOI] [PubMed] [Google Scholar]
  2. Burland W. L., Hawkins B. W., Beresford J. Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study. Postgrad Med J. 1980 Mar;56(653):173–176. doi: 10.1136/pgmj.56.653.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hamilton I., Worsley B. W., O'Connor H. J., Axon A. T. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer. Gut. 1983 Dec;24(12):1148–1151. doi: 10.1136/gut.24.12.1148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kang J. Y., Piper D. W. Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Comparison of initial healing and recurrence after healing. Digestion. 1982;23(2):73–79. doi: 10.1159/000198690. [DOI] [PubMed] [Google Scholar]
  5. Marshall B. J., Warren J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984 Jun 16;1(8390):1311–1315. doi: 10.1016/s0140-6736(84)91816-6. [DOI] [PubMed] [Google Scholar]
  6. Martin D. F., Hollanders D., May S. J., Ravenscroft M. M., Tweedle D. E., Miller J. P. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet. 1981 Jan 3;1(8210):7–10. doi: 10.1016/s0140-6736(81)90114-8. [DOI] [PubMed] [Google Scholar]
  7. McLean A. J., Harrison P. M., Ioannides-Demos L. L., Byrne A. J., McCarthy P., Dudley F. J. Microbes, peptic ulcer, and relapse rates with different drugs. Lancet. 1984 Sep 1;2(8401):525–526. doi: 10.1016/s0140-6736(84)92607-2. [DOI] [PubMed] [Google Scholar]
  8. Moshal M. G., Gregory M. A., Pillay C., Spitaels J. M. Does the duodenal cell ever return to normal? A comparison between treatment with cimetidine and denol. Scand J Gastroenterol Suppl. 1979;54:48–51. [PubMed] [Google Scholar]
  9. Ström M., Gotthard R., Bodemar G., Walan A. Antacid/anticholinergic, cimetidine, and placebo in treatment of active peptic ulcers. Scand J Gastroenterol. 1981;16(5):593–602. doi: 10.3109/00365528109182017. [DOI] [PubMed] [Google Scholar]
  10. Vantrappen G., Rutgeerts P., Broeckaert L., Janssens J. Randomised open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer. Gut. 1980 Apr;21(4):329–333. doi: 10.1136/gut.21.4.329. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES